Ignite Creation Date:
2025-12-25 @ 12:20 AM
Ignite Modification Date:
2025-12-25 @ 10:24 PM
Study NCT ID:
NCT02287558
Status:
COMPLETED
Last Update Posted:
2020-07-15
First Post:
2014-11-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Pomalidomide in Hereditary Hemorrhagic Telangiectasia and Transfusion-Dependent Vascular Ectasia: a Phase I Study
Sponsor:
The Cleveland Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-01-27
Start Date Type:
ACTUAL
Primary Completion Date:
2019-06-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-06-01
Completion Date Type:
ACTUAL
First Submit Date:
2014-11-06
First Submit QC Date:
None
Study First Post Date:
2014-11-10
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-13
Last Update Post Date:
2020-07-15
Last Update Post Date Type:
ACTUAL